Optical Image-guided Surgery—Where Do We Stand?

In cancer surgery, intra-operative assessment of the tumor-free margin, which is critical for the prognosis of the patient, relies on the visual appearance and palpation of the tumor. Optical imaging techniques provide real-time visualization of the tumor, warranting intra-operative image-guided surgery. Within this field, imaging in the near-infrared light spectrum offers two essential advantages: increased tissue penetration of light and an increased signal-to-background-ratio of contrast agents. In this article, we review the various techniques, contrast agents, and camera systems that are currently used for image-guided surgery. Furthermore, we provide an overview of the wide range of molecular contrast agents targeting specific hallmarks of cancer and we describe perspectives on its future use in cancer surgery.

[1]  V. Chernomordik,et al.  Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging , 2008, Clinical Cancer Research.

[2]  Wafik El-Deiry,et al.  Noninvasive vascular imaging in fluorescent tumors using multispectral unmixing. , 2008, BioTechniques.

[3]  A. Grichine,et al.  In Vivo Noninvasive Optical Imaging of Receptor-Mediated RGD Internalization Using Self-Quenched Cy5-Labeled RAFT-c(-RGDfK-)4 , 2007, Molecular imaging.

[4]  Hisataka Kobayashi,et al.  Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. , 2009, Molecular pharmaceutics.

[5]  S Nioka,et al.  NIR Spectroscopic Detection of Breast Cancer , 2005, Technology in cancer research & treatment.

[6]  Tim Liedl,et al.  Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. , 2005, Nano letters.

[7]  B. Rice,et al.  In-vivo fluorescence imaging with a multivariate curve resolution spectral unmixing technique. , 2009, Journal of biomedical optics.

[8]  Takeaki Ishizawa,et al.  Real‐time identification of liver cancers by using indocyanine green fluorescent imaging , 2009, Cancer.

[9]  Xiaoyuan Chen,et al.  RGD-Human Serum Albumin Conjugates as Efficient Tumor Targeting Probes , 2009, Molecular imaging.

[10]  R. Richards-Kortum,et al.  Multispectral optical imaging device for in vivo detection of oral neoplasia. , 2008, Journal of biomedical optics.

[11]  Rebecca Richards-Kortum,et al.  Optical contrast agents and imaging systems for detection and diagnosis of cancer , 2008, International journal of cancer.

[12]  K. Maquelin,et al.  Discrimination between nontumor bladder tissue and tumor by Raman spectroscopy. , 2006, Analytical chemistry.

[13]  Ulrich Wiesner,et al.  Core-shell silica nanoparticles as fluorescent labels for nanomedicine. , 2007, Journal of biomedical optics.

[14]  Liyi Shi,et al.  Biodistribution and toxicity of intravenously administered silica nanoparticles in mice , 2010, Archives of Toxicology.

[15]  Haishan Zeng,et al.  Simple device for the direct visualization of oral-cavity tissue fluorescence. , 2006, Journal of biomedical optics.

[16]  Clifford Hoyt,et al.  Visualization of Microscopy‐Based Spectral Imaging Data from Multi‐Label Tissue Sections , 2008, Current protocols in molecular biology.

[17]  Ralph Weissleder,et al.  Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.

[18]  E. Rosenthal,et al.  Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment , 2007, Cancer biology & therapy.

[19]  J. Roodenburg,et al.  The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. , 2005, Oral oncology.

[20]  Aya Nakagawa,et al.  Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. , 2008, American journal of surgery.

[21]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[22]  Wei Min,et al.  Imaging chromophores with undetectable fluorescence by stimulated emission microscopy , 2009, Nature.

[23]  X. Intes Time-Domain Optical Mammography SoftScan , 2005 .

[24]  Bohumil Bednar,et al.  Dual In Vivo Quantification of Integrin-targeted and Protease-activated Agents in Cancer Using Fluorescence Molecular Tomography (FMT) , 2010, Molecular Imaging and Biology.

[25]  G. Semenza,et al.  'The metabolism of tumours': 70 years later. , 2001, Novartis Foundation symposium.

[26]  H. Barr,et al.  Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus , 2006, British Journal of Cancer.

[27]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[28]  Soren D. Konecky,et al.  Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. , 2009, Journal of biomedical optics.

[29]  L. Ngo,et al.  The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping , 2009, Annals of Surgical Oncology.

[30]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[31]  P. Choyke,et al.  Imaging of the lymphatic system: new horizons. , 2006, Contrast media & molecular imaging.

[32]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[33]  Ken Hayashi,et al.  Image-Guided Liver Mapping Using Fluorescence Navigation System with Indocyanine Green for Anatomical Hepatic Resection , 2008, World Journal of Surgery.

[34]  H. Barr,et al.  Raman Spectroscopy for Early Detection of Laryngeal Malignancy: Preliminary Results , 2000, The Laryngoscope.

[35]  Marina V Backer,et al.  Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes , 2007, Nature Medicine.

[36]  Z. Fayad,et al.  Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots , 2008, Angiogenesis.

[37]  Brian C Wilson,et al.  Molecular Fluorescence Excitation–Emission Matrices Relevant to Tissue Spectroscopy¶ , 2003, Photochemistry and photobiology.

[38]  Arya Nabavi,et al.  FIVE‐AMINOLEVULINIC ACID FOR FLUORESCENCE‐GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS: A PHASE II STUDY , 2009, Neurosurgery.

[39]  G. Puppels,et al.  Towards oncological application of Raman spectroscopy , 2009, Journal of biophotonics.

[40]  Stephanie Alexander,et al.  Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model , 2008, Histochemistry and Cell Biology.

[41]  J. Frangioni,et al.  An Operational Near-Infrared Fluorescence Imaging System Prototype for Large Animal Surgery , 2003, Technology in cancer research & treatment.

[42]  R. Weissleder,et al.  Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer , 2006, International journal of cancer.

[43]  M. Simpson,et al.  Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice. , 2007, Analytical biochemistry.

[44]  Christoph Bremer,et al.  Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe , 2003, European Radiology.

[45]  A. Wunder,et al.  Molecular imaging: novel tools in visualizing rheumatoid arthritis. , 2005, Rheumatology.

[46]  Vasilis Ntziachristos,et al.  Real-time intraoperative fluorescence imaging system using light-absorption correction. , 2009, Journal of biomedical optics.

[47]  U. Dirnagl,et al.  In Vivo Near-Infrared Fluorescence Imaging of Matrix Metalloproteinase Activity after Cerebral Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  X. Intes Time-domain optical mammography SoftScan: initial results. , 2005, Academic radiology.

[49]  Annette McWilliams,et al.  Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma In situ , 2009, Clinical Cancer Research.

[50]  Shi Ke,et al.  Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. , 2007, Journal of biomedical optics.

[51]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  Ralph P. Mason,et al.  Dynamic Near-Infrared Optical Imaging of 2-Deoxyglucose Uptake by Intracranial Glioma of Athymic Mice , 2009, PloS one.

[54]  J. Humm,et al.  A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probes , 2008, Surgical Endoscopy.

[55]  K. Badizadegan,et al.  NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes. , 2002, Cancer research.

[56]  E. Rosenthal,et al.  Assessment of Bevacizumab Conjugated to Cy5.5 for Detection of Head and Neck Cancer Xenografts , 2008, Technology in cancer research & treatment.